Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 121


Efficacy and safety of endostar® combined with chemotherapy in patients with advanced soft tissue sarcomas.

Zhang LP, Liao XY, Xu YM, Yan LJ, Yan GF, Wang XX, Duan YZ, Sun JG.

Asian Pac J Cancer Prev. 2013;14(7):4255-9.


Retrospective analysis of 498 primary soft tissue sarcomas in a single Turkish centre.

Duman BB, Gunaldi M, Ercolak V, Afsar CU, Sahin B, Erkisi IM, Kara O, Paydas S, Gönlüsen G, Sertdemir Y.

Asian Pac J Cancer Prev. 2012;13(8):4125-8.


Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.

Look Hong NJ, Hornicek FJ, Harmon DC, Choy E, Chen YL, Yoon SS, Nielsen GP, Szymonifka J, Yeap BY, DeLaney TF, Mullen JT.

Eur J Cancer. 2013 Mar;49(4):875-83. doi: 10.1016/j.ejca.2012.10.002. Epub 2012 Oct 22.


[Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status].

Guo GF, Xia LP, Qiu HJ, Xu RH, Zhang B, Jiang WQ, Zhou FF, Wang F.

Zhonghua Zhong Liu Za Zhi. 2010 Oct;32(10):777-81. Chinese.


[Treatment and prognosis of stage IV alveolar soft part sarcoma].

Zhao J, Yang Y.

Zhonghua Zhong Liu Za Zhi. 2012 Dec;34(12):932-6. doi: 10.3760/cma.j.issn.0253-3766.2012.12.011. Chinese.


[Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer].

Li N, Jin ZL, Liu ZJ, Wang J, Li K.

Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):937-42. Chinese.


Clinical Application of Recombinant Human Endostatin in Postoperative Early Complementary Therapy on Patients with Non-small Cell Lung Cancer in Chinese Mainland.

Zhu Q, Zang Q, Jiang ZM, Wang W, Cao M, Su GZ, Zhen TC, Zhang XT, Sun NB, Zhao C.

Asian Pac J Cancer Prev. 2015;16(9):4013-8.


[Results of isolated hyperthermic extremity perfusion in soft tissue sarcomas within the scope of a multimodality treatment concept].

Schwarzbach M, Lehnert T, Willeke F, Hinz U, Herfarth C.

Chirurg. 1996 Dec;67(12):1237-43. German.


[A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)].

Han BH, Xiu QY, Wang HM, Shen J, Gu AQ, Luo Y, Bai CX, Guo SL, Liu WC, Zhuang ZX, Zhang Y, Zhao YZ, Jiang LY, Shi CL, Jin B, Zhou JY, Jin XQ.

Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):854-9. Chinese.


Clinical observation on recombinant human endostatin combined with chemotherapy for advanced gastrointestinal cancer.

Gao SR, Li LM, Xia HP, Wang GM, Xu HY, Wang AR.

Asian Pac J Cancer Prev. 2015;16(9):4037-40.


Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.

Lashkari A, Chow WA, Valdes F, Leong L, Phan V, Twardowski P, Kapoor N, Molina A, Al-Kadhimi Z, Frankel P, Somlo G.

Anticancer Res. 2009 Aug;29(8):3281-8.


Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.

Karavasilis V, Seddon BM, Ashley S, Al-Muderis O, Fisher C, Judson I.

Cancer. 2008 Apr 1;112(7):1585-91. doi: 10.1002/cncr.23332.


Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.

Ghaemmaghami F, Karimi-Zarchi M, Gilani MM, Mousavi A, Behtash N, Ghasemi M.

Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):421-6.


[Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].

Lehnhardt M, Hirche C, Daigeler A, Goertz O, Ring A, Hirsch T, Drücke D, Hauser J, Steinau HU.

Chirurg. 2012 Feb;83(2):143-52. doi: 10.1007/s00104-011-2124-6. German. Erratum in: Chirurg. 2012 May;83(5):485-6.


[Neoadjuvant radiochemotherapy in soft tissue sarcomas. Optimization of local functional tumor control].

Sauer R, Schuchardt U, Hohenberger W, Wittekind C, Papadopoulos T, Grabenbauer GG, Fietkau R.

Strahlenther Onkol. 1999 Jun;175(6):259-66. German.


FOLFOX-4 regimen or single-agent gemcitabine as first-line chemotherapy in advanced biliary tract cancer.

Novarino AM, Satolli MA, Chiappino I, Giacobino A, Napoletano R, Ceccarelli M, Ciccone G, Schena M, Bertetto O, Ciuffreda L.

Am J Clin Oncol. 2013 Oct;36(5):466-71. doi: 10.1097/COC.0b013e31825691c3.


The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.

Farid M, Ong WS, Tan MH, Foo LS, Lim YK, Chia WK, Soh LT, Poon D, Lee MJ, Ho ZC, Jeevan R, Chin F, Teo M, Quek R.

Am J Clin Oncol. 2013 Aug;36(4):368-74. doi: 10.1097/COC.0b013e318248dbf4.


Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.

Koscielniak E, Jürgens H, Winkler K, Bürger D, Herbst M, Keim M, Bernhard G, Treuner J.

Cancer. 1992 Nov 15;70(10):2557-67.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk